Cardio-Thoracic Surgery Department, Heart and Vascular Centre, Maastricht University Medical Centre, Maastricht, The Netherlands.
Cardiac Surgery Unit, University of Chieti, Chieti, Italy.
Crit Care. 2021 Mar 17;25(1):107. doi: 10.1186/s13054-021-03533-5.
Single- (SL) and double-lumen (DL) catheters are used in clinical practice for veno-venous extracorporeal membrane oxygenation (V-V ECMO) therapy. However, information is lacking regarding the effects of the cannulation on neurological complications.
A retrospective observational study based on data from the Extracorporeal Life Support Organization (ELSO) registry. All adult patients included in the ELSO registry from 2011 to 2018 submitted to a single run of V-V ECMO were analyzed. Propensity score (PS) inverse probability of treatment weighting estimation for multiple treatments was used. The average treatment effect (ATE) was chosen as the causal effect estimate of outcome. The aim of the study was to evaluate differences in the occurrence and the type of neurological complications in adult patients undergoing V-V ECMO when treated with SL or DL cannulas.
From a population of 6834 patients, the weighted propensity score matching included 6245 patients (i.e., 91% of the total cohort; 4175 with SL and 20,270 with DL cannulation). The proportion of patients with at least one neurological complication was similar in the SL (306, 7.2%) and DL (189, 7.7%; odds ratio 1.10 [95% confidence intervals 0.91-1.32]; p = 0.33). After weighted propensity score, the ATE for the occurrence of least one neurological complication was 0.005 (95% CI - 0.009 to 0.018; p = 0.50). Also, the occurrence of specific neurological complications, including intracerebral hemorrhage, acute ischemic stroke, seizures or brain death, was similar between groups. Overall mortality was similar between patients with neurological complications in the two groups.
In this large registry, the occurrence of neurological complications was not related to the type of cannulation in patients undergoing V-V ECMO.
单腔(SL)和双腔(DL)导管在临床实践中用于静脉-静脉体外膜肺氧合(V-V ECMO)治疗。然而,关于置管对神经并发症影响的信息还很缺乏。
这是一项基于体外生命支持组织(ELSO)登记处数据的回顾性观察研究。分析了 2011 年至 2018 年期间向 ELSO 登记处提交的所有接受单次 V-V ECMO 治疗的成年患者。采用倾向评分(PS)逆概率处理加权法进行多重处理。选择平均治疗效果(ATE)作为结局的因果效应估计值。本研究旨在评估在接受 V-V ECMO 治疗的成年患者中,使用 SL 或 DL 导管时,神经并发症的发生和类型是否存在差异。
从 6834 例患者中,加权倾向评分匹配纳入了 6245 例患者(即总队列的 91%;4175 例使用 SL 导管,20270 例使用 DL 导管)。SL 组(306 例,7.2%)和 DL 组(189 例,7.7%;优势比 1.10[95%置信区间 0.91-1.32];p=0.33)至少有一种神经并发症的患者比例相似。经加权倾向评分后,至少有一种神经并发症发生的 ATE 为 0.005(95%CI-0.009 至 0.018;p=0.50)。此外,两组之间特定的神经并发症(包括颅内出血、急性缺血性卒中、癫痫发作或脑死亡)的发生率也相似。两组中发生神经并发症的患者的总体死亡率相似。
在这项大型登记研究中,在接受 V-V ECMO 的患者中,神经并发症的发生与置管类型无关。